Patents by Inventor Stuart L. Goldstein

Stuart L. Goldstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Uses of transdermal glomerular filtration rate measurement in continuous renal replacement therapy
    Patent number: 12102432
    Abstract: Disclosed herein is a method for determining a dosing prescription for a medicament in a patient undergoing CRRT. The method generally includes administering to the bloodstream of the patient a fluorescent agent; administering to the patient at least one dose of the medicament; performing CRRT on the patient after administering the fluorescent agent to the patient; exposing the fluorescent agent to visible or infrared light; monitoring transcutaneously a change in the spectral energy from the fluorescent agent over a period of time; correlating a change in intensity of the spectral energy from the fluorescent agent to a clearance rate of the fluorescent agent from the bloodstream in the patient; calculating a clearance rate of the medicament in the patient; determining an amount of the medicament in the bloodstream of the patient as a function of time; and adjusting a dosing prescription of the medicament to the patient.
    Type: Grant
    Filed: August 27, 2019
    Date of Patent: October 1, 2024
    Assignee: MEDIBEACON, INC.
    Inventors: Stuart L. Goldstein, Richard B. Dorshow
  • USES OF TRANSDERMAL GLOMERULAR FILTRATION RATE MEASUREMENT IN CONTINUOUS RENAL REPLACEMENT THERAPY
    Publication number: 20200187838
    Abstract: Disclosed herein is a method for determining a dosing prescription for a medicament in a patient undergoing CRRT. The method generally includes administering to the bloodstream of the patient a fluorescent agent; administering to the patient at least one dose of the medicament; performing CRRT on the patient after administering the fluorescent agent to the patient; exposing the fluorescent agent to visible or infrared light; monitoring transcutaneously a change in the spectral energy from the fluorescent agent over a period of time; correlating a change in intensity of the spectral energy from the fluorescent agent to a clearance rate of the fluorescent agent from the bloodstream in the patient; calculating a clearance rate of the medicament in the patient; determining an amount of the medicament in the bloodstream of the patient as a function of time; and adjusting a dosing prescription of the medicament to the patient.
    Type: Application
    Filed: August 27, 2019
    Publication date: June 18, 2020
    Inventors: Stuart L. Goldstein, Richard B. Dorshow